370 related articles for article (PubMed ID: 10179922)
1. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol.
Goldstein JL; Larson LR; Yamashita BD
Am J Manag Care; 1998 May; 4(5):687-97. PubMed ID: 10179922
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.
Kristiansen IS; Kvien TK; Nord E
Arthritis Rheum; 1999 Nov; 42(11):2293-302. PubMed ID: 10555023
[TBL] [Abstract][Full Text] [Related]
3. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
[TBL] [Abstract][Full Text] [Related]
4. Gastroprotective strategies in chronic NSAID users: a cost-effectiveness analysis comparing single-tablet formulations with individual components.
de Groot NL; Spiegel BM; van Haalen HG; de Wit NJ; Siersema PD; van Oijen MG
Value Health; 2013; 16(5):769-77. PubMed ID: 23947970
[TBL] [Abstract][Full Text] [Related]
5. Diclofenac/misoprostol: novel findings and their clinical potential.
Shield MJ
J Rheumatol Suppl; 1998 May; 51():31-41. PubMed ID: 9596552
[TBL] [Abstract][Full Text] [Related]
6. Diclofenac/misoprostol: the European clinical experience.
McKenna F
J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
[TBL] [Abstract][Full Text] [Related]
7. Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis? A review of conflicting economic evaluations.
Stucki G; Johannesson M; Liang MH
Arch Intern Med; 1994 Sep; 154(18):2020-5. PubMed ID: 8092907
[TBL] [Abstract][Full Text] [Related]
8. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
Fialová P; Vlcek J
Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
[TBL] [Abstract][Full Text] [Related]
9. NSAID gastropathy. A new understanding.
Roth SH
Arch Intern Med; 1996 Aug 12-26; 156(15):1623-8. PubMed ID: 8694659
[TBL] [Abstract][Full Text] [Related]
10. The evolution of arthritis antiinflammatory care: where are we today?
Simon LS
J Rheumatol Suppl; 1999 Apr; 56():11-7. PubMed ID: 10225535
[TBL] [Abstract][Full Text] [Related]
11. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
12. Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands.
Al MJ; Maniadakis N; Grijseels EW; Janssen M
Value Health; 2008; 11(4):589-99. PubMed ID: 18194404
[TBL] [Abstract][Full Text] [Related]
13. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
Bakowsky VS; Hanly JG
J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatories and gastroduodenal damage: therapeutic options.
Agrawal NM
Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
Geis GS; Stead H; Wallemark CB; Nicholson PA
J Rheumatol Suppl; 1991 Mar; 28():11-4. PubMed ID: 1903808
[TBL] [Abstract][Full Text] [Related]
16. A pharmacoeconomic comparison of misoprostol/diclofenac with diclofenac.
Morant SV; Shield MJ; Davey PG; MacDonald TM
Pharmacoepidemiol Drug Saf; 2002; 11(5):393-400. PubMed ID: 12271881
[TBL] [Abstract][Full Text] [Related]
17. Management of NSAID-induced gastropathy: an economic decision analysis.
Goldstein JL; Larson LR; Yamashita BD; Boyd MS
Clin Ther; 1997; 19(6):1496-509; discussion 1424-5. PubMed ID: 9444455
[TBL] [Abstract][Full Text] [Related]
18. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
Vakil N
Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
[TBL] [Abstract][Full Text] [Related]
19. [Is misoprostol effective in NSAID-induced gastrointestinal complications?].
Stucki G; Sangha O; Michel BA
Schweiz Med Wochenschr; 1996 Sep; 126(37):1573-8. PubMed ID: 8927962
[TBL] [Abstract][Full Text] [Related]
20. Arthrotec: a therapeutic option in the management of arthritis.
Geis GS
Eur J Rheumatol Inflamm; 1993; 13(1):25-32. PubMed ID: 7821336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
